1
|
Wanderley MC, Soares CMA, Morais MMM, Cruz RM, Lima IRM, Chojniak R, Bitencourt AGV. Application of artificial intelligence in predicting malignancy risk in breast masses on ultrasound. Radiol Bras 2023; 56:229-234. [PMID: 38204896 PMCID: PMC10775818 DOI: 10.1590/0100-3984.2023.0034] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2023] [Revised: 05/16/2023] [Accepted: 07/05/2023] [Indexed: 01/12/2024] Open
Abstract
Objective To evaluate the results obtained with an artificial intelligence-based software for predicting the risk of malignancy in breast masses from ultrasound images. Materials and Methods This was a retrospective, single-center study evaluating 555 breast masses submitted to percutaneous biopsy at a cancer referral center. Ultrasonographic findings were classified in accordance with the BI-RADS lexicon. The images were analyzed by using Koios DS Breast software and classified as benign, probably benign, low to intermediate suspicion, high suspicion, or probably malignant. The histological classification was considered the reference standard. Results The mean age of the patients was 51 years, and the mean mass size was 16 mm. The radiologist evaluation had a sensitivity and specificity of 99.1% and 34.0%, respectively, compared with 98.2% and 39.0%, respectively, for the software evaluation. The positive predictive value for malignancy for the BI-RADS categories was similar between the radiologist and software evaluations. Two false-negative results were identified in the radiologist evaluation, the masses in question being classified as suspicious by the software, whereas four false-negative results were identified in the software evaluation, the masses in question being classified as suspicious by the radiologist. Conclusion In our sample, the performance of artificial intelligence-based software was comparable to that of a radiologist.
Collapse
Affiliation(s)
| | | | | | | | | | - Rubens Chojniak
- Department of Imaging, A.C.Camargo Cancer Center, São Paulo,
SP, Brazil
| | | |
Collapse
|
2
|
Moustafa AF, Cary TW, Sultan LR, Schultz SM, Conant EF, Venkatesh SS, Sehgal CM. Color Doppler Ultrasound Improves Machine Learning Diagnosis of Breast Cancer. Diagnostics (Basel) 2020; 10:diagnostics10090631. [PMID: 32854253 PMCID: PMC7555557 DOI: 10.3390/diagnostics10090631] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2020] [Revised: 08/20/2020] [Accepted: 08/21/2020] [Indexed: 12/16/2022] Open
Abstract
Color Doppler is used in the clinic for visually assessing the vascularity of breast masses on ultrasound, to aid in determining the likelihood of malignancy. In this study, quantitative color Doppler radiomics features were algorithmically extracted from breast sonograms for machine learning, producing a diagnostic model for breast cancer with higher performance than models based on grayscale and clinical category from the Breast Imaging Reporting and Data System for ultrasound (BI-RADSUS). Ultrasound images of 159 solid masses were analyzed. Algorithms extracted nine grayscale features and two color Doppler features. These features, along with patient age and BI-RADSUS category, were used to train an AdaBoost ensemble classifier. Though training on computer-extracted grayscale features and color Doppler features each significantly increased performance over that of models trained on clinical features, as measured by the area under the receiver operating characteristic (ROC) curve, training on both color Doppler and grayscale further increased the ROC area, from 0.925 ± 0.022 to 0.958 ± 0.013. Pruning low-confidence cases at 20% improved this to 0.986 ± 0.007 with 100% sensitivity, whereas 64% of the cases had to be pruned to reach this performance without color Doppler. Fewer borderline diagnoses and higher ROC performance were both achieved for diagnostic models of breast cancer on ultrasound by machine learning on color Doppler features.
Collapse
Affiliation(s)
- Afaf F. Moustafa
- New York Medical College, Valhalla, NY 10595, USA;
- Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA; (L.R.S.); (S.M.S.); (E.F.C.); (C.M.S.)
| | - Theodore W. Cary
- Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA; (L.R.S.); (S.M.S.); (E.F.C.); (C.M.S.)
- Correspondence: ; Tel.: +1-215-817-0809; Fax: +1-215-898-6115
| | - Laith R. Sultan
- Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA; (L.R.S.); (S.M.S.); (E.F.C.); (C.M.S.)
| | - Susan M. Schultz
- Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA; (L.R.S.); (S.M.S.); (E.F.C.); (C.M.S.)
| | - Emily F. Conant
- Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA; (L.R.S.); (S.M.S.); (E.F.C.); (C.M.S.)
| | - Santosh S. Venkatesh
- Department of Electrical and Systems Engineering, University of Pennsylvania, Philadelphia, PA 19104, USA;
| | - Chandra M. Sehgal
- Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA; (L.R.S.); (S.M.S.); (E.F.C.); (C.M.S.)
| |
Collapse
|
5
|
Pinder LF, Henry-Tillman R, Linyama D, Kusweje V, Nzayisenga JB, Shibemba A, Sahasrabuddhe V, Lishimpi K, Mwanahamuntu M, Hicks M, Parham GP. Leverage of an Existing Cervical Cancer Prevention Service Platform to Initiate Breast Cancer Control Services in Zambia: Experiences and Early Outcomes. J Glob Oncol 2017; 4:1-8. [PMID: 30241176 PMCID: PMC6180756 DOI: 10.1200/jgo.17.00026] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
PURPOSE In 2005, the Cervical Cancer Prevention Program in Zambia (CCPPZ) was implemented and has since provided cervical cancer screen-and-treat services to more than 500,000 women. By leveraging the successes and experiences of the CCPPZ, we intended to build capacity for the early detection and surgical treatment of breast cancer. METHODS Our initiative sought to build capacity for breast cancer care through the (1) formation of a breast cancer advocacy alliance to raise awareness, (2) creation of resource-appropriate breast cancer care training curricula for mid- and high-level providers, and (3) implementation of early detection and treatment capacity within two major health care facilities. RESULTS Six months after the completion of the initiative, the following outcomes were documented: Breast health education and clinical breast examination (CBE) services were successfully integrated into the service platforms of four CCPPZ clinics. Two new breast diagnostic centers were opened, which provided access to breast ultrasound, ultrasound-guided core needle biopsy, and needle aspiration. Breast health education and CBE were provided to 1,955 clients, 167 of whom were evaluated at the two diagnostic centers; 55 of those evaluated underwent core-needle biopsy, of which 17 were diagnosed with invasive cancer. Newly trained surgeons performed six sentinel lymph node mappings, eight sentinel lymph node dissections, and 10 breast conservation surgeries (lumpectomies). CONCLUSION This initiative successfully established clinical services in Zambia that are critical for the early detection and surgical management of breast cancer.
Collapse
Affiliation(s)
- Leeya F Pinder
- Leeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD
| | - Ronda Henry-Tillman
- Leeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD
| | - David Linyama
- Leeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD
| | - Victor Kusweje
- Leeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD
| | - Jean-Baptiste Nzayisenga
- Leeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD
| | - Aaron Shibemba
- Leeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD
| | - Vikrant Sahasrabuddhe
- Leeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD
| | - Kennedy Lishimpi
- Leeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD
| | - Mulindi Mwanahamuntu
- Leeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD
| | - Michael Hicks
- Leeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD
| | - Groesbeck P Parham
- Leeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD
| |
Collapse
|
9
|
Brusseau E, Detti V, Coulon A, Maissiat E, Boublay N, Berthezène Y, Fromageau J, Bush N, Bamber J. In Vivo response to compression of 35 breast lesions observed with a two-dimensional locally regularized strain estimation method. ULTRASOUND IN MEDICINE & BIOLOGY 2014; 40:300-12. [PMID: 24315397 DOI: 10.1016/j.ultrasmedbio.2013.02.017] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/07/2012] [Revised: 02/16/2013] [Accepted: 02/21/2013] [Indexed: 06/02/2023]
Abstract
The objective of this study was to assess the in vivo performance of our 2-D locally regularized strain estimation method with 35 breast lesions, mainly cysts, fibroadenomas and carcinomas. The specific 2-D deformation model used, as well as the method's adaptability, led to an algorithm that is able to track tissue motion from radiofrequency ultrasound images acquired in clinical conditions. Particular attention was paid to strain estimation reliability, implying analysis of the mean normalized correlation coefficient maps. For all lesions examined, the results indicated that strain image interpretation, as well as its comparison with B-mode data, should take into account the information provided by the mean normalized correlation coefficient map. Different trends were observed in the tissue response to compression. In particular, carcinomas appeared larger in strain images than in B-mode images, resulting in a mean strain/B-mode lesion area ratio of 2.59 ± 1.36. In comparison, the same ratio was assessed as 1.04 ± 0.26 for fibroadenomas. These results are in agreement with those of previous studies, and confirm the interest of a more thorough consideration of size difference as one parameter discriminating between malignant and benign lesions.
Collapse
Affiliation(s)
- Elisabeth Brusseau
- Université de Lyon, CREATIS, CNRS UMR5220, Inserm U1044, INSA-Lyon, Université Lyon 1, France.
| | - Valérie Detti
- Université de Lyon, CREATIS, CNRS UMR5220, Inserm U1044, INSA-Lyon, Université Lyon 1, France
| | - Agnès Coulon
- Hospices Civils de Lyon, Service de Radiologie, Hôpital de la Croix-Rousse, Lyon, France
| | - Emmanuèle Maissiat
- Hospices Civils de Lyon, Service de Radiologie, Hôpital de la Croix-Rousse, Lyon, France
| | - Nawele Boublay
- Hospices Civils de Lyon, Pôle Information Médicale Evaluation Recherche, Lyon, France; Université Lyon 1, Equipe d'Accueil 4129, France; Centre Mémoire de Ressources et de Recherche (CMRR), Hôpital des Charpennes, Lyon, France
| | - Yves Berthezène
- Université de Lyon, CREATIS, CNRS UMR5220, Inserm U1044, INSA-Lyon, Université Lyon 1, France; Hospices Civils de Lyon, Service de Radiologie, Hôpital de la Croix-Rousse, Lyon, France
| | - Jérémie Fromageau
- Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey, UK
| | - Nigel Bush
- Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey, UK
| | - Jeffrey Bamber
- Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey, UK
| |
Collapse
|